Results 21 to 30 of about 75,345 (303)

Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study

open access: yesFrontiers in Immunology, 2023
Oral immunization is an effective strategy for inducing protective immunity against mucosal enteric pathogens. Although live-attenuated as well as subunit approaches have been explored for vaccination against enteric pathogens, inactivated whole ...
Richard I. Walker, A. Louis Bourgeois
doaj   +1 more source

Role of the immune system and possible mechanisms in COVID-19 vaccine-induced thyroiditis: Case report and literature review

open access: yesJournal of Clinical and Translational Endocrinology Case Reports, 2022
Introduction: Subacute thyroiditis (SAT) is an inflammatory disease that has different trigger factors. Recent studies show the possible role of COVID-19 vaccine-induced thyroiditis in its initiation.
Vahid Reisi-Vanani   +5 more
doaj   +1 more source

Imiquimod: an old molecule with potentialities against COVID-19

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2020
Full text (en español)
Alberto José Piamo-Morales
doaj  

Clinical features in patients with long-lasting macrophagic myofasciitis

open access: yesFrontiers in Neurology, 2014
Macrophagic myofasciitis (MMF) is an emerging condition characterized by specific muscle lesions assessing abnormal long-term persistence of aluminium hydroxide within macrophages at the site of previous immunization. Affected patients usually are middle-
Muriel eRIGOLET   +14 more
doaj   +1 more source

Isolation and Analysis of Stromal Cell Populations from Mouse Lymph Nodes

open access: yesBio-Protocol, 2017
Our protocol describes a simple procedure for isolating stromal cells from lymph nodes (LN). LN are disrupted then enzymatically digested with collagenase and dispase to produce a single cell suspension that can be stained with fluorescently labelled ...
Yannick Alexandre, Scott Mueller
doaj   +1 more source

Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.

open access: yes, 2011
T cell-based cancer immunotherapy relies on advancements made over the last 20 years on the molecular mechanisms underlying the antigenicity of tumors. This review focuses on human tumor antigens recognized by T lymphocytes, particularly the reasons why ...
Coulie, Pierre   +5 more
core   +1 more source

Yavar-70A, a novel water-in-oil adjuvant: A potency study in HPV-16E7d vaccine model [PDF]

open access: yesIranian Journal of Basic Medical Sciences
Objective(s): Adjuvants are some of the most important components used for vaccine formulation. In addition, the efficacy of vaccines is highly dependent on the nature of the adjuvants used.
Zeinab Mirzaei   +6 more
doaj   +1 more source

Archaeosome Adjuvant Overcomes Tolerance to Tumor-Associated Melanoma Antigens Inducing Protective CD8+ T Cell Responses

open access: yesClinical and Developmental Immunology, 2010
Vesicles comprised of the ether glycerolipids of the archaeon Methanobrevibacter smithii (archaeosomes) are potent adjuvants for evoking CD8+ T cell responses.
Lakshmi Krishnan   +4 more
doaj   +1 more source

Metastatic niche shaped by host factors influences disseminated cancer cell fate

open access: yesFEBS Letters, EarlyView.
Metastasis is shaped not only by cancer cells but also by the environments they encounter. This review explores how factors such as aging, diet, the microbiome, lifestyle, and environmental exposures remodel organ‐specific niches in the lung, liver, bone, and brain, influencing where metastatic cells survive, remain dormant, or grow, and ultimately ...
Gwennan Delyth Ward   +2 more
wiley   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

open access: yesMolecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy